ACOT12 and metabolic dysfunction-associated steatotic liver disease: In summary, in this study, we found that ACOT12 deficiency may be responsible for the pathogenesis of NAFLD through the accumulation of cholesterol in the liver and suggest that Acot12 could be a promising therapeutic therapy for controlling NAFLD.